Tag archive for ‘Actavis’
Kurt Tucholsky On Wednesday, May 13th, 2015

Actavis CEO: Teva-Mylan Deal to Create ‘Bad Blood’, Destroy Value

    As Israeli pharmaceutical giant Teva pushes ahead with a $40-billion dollar hostile bid for US generic drugmaker Mylan, Brent Saunders, CEO of rival drug manufacturer Actavis, has raised concerns More...

Vered Weiss On Thursday, February 12th, 2015

Allergan CEO Says Fighting Off Activist Bill Ackman Was Full Time Job

One thing Allergan CEO David Pyott enjoyed doing was running his company. When activist investor Bill Ackman of Pershing Square decided to have Valeant Pharmaceuticals try to swallow up the Botox maker in a More...

Eli Horn On Tuesday, February 3rd, 2015

Bill Ackman Not Likely to Plunk Down Cash Hoard Anytime Soon

The comparatively low level of cash assets currently held by hedge fund mogul Bill Ackman probably means that he won’t be making any activist investments for the next few months. Ackman’s $18.3 billion Pershing More...

Vered Weiss On Wednesday, January 7th, 2015

Alpha Wolf Bill Ackman Is Top Dog on Wall Street

Bill Ackman might be controversial, but he had the top performing hedge fund of 2014, as reported by Bloomberg. While he was ridiculed the previous year for his pressure to put Ron Johnson of AppleStores as More...

Vered Weiss On Tuesday, December 30th, 2014

Is Bill Ackman Guilty of Insider Trading?

Bill Ackman has cleaned up this year to the tune of $1 billion. He has also profited from Actavis’ announced merger with Botox maker Allergan, although for many months, he was pushing the company to accept More...

Reuters On Wednesday, November 26th, 2014

Ackman’s Pershing Square sees big payoff from Allergan deal

–   Hedge fund mogul William Ackman told investors they could see a $6 billion payday when he closes the chapter on Allergan Inc., his firm’s biggest bet of 2014. One week after Allergan agreed More...

Tibi Singer On Wednesday, November 26th, 2014

Actavis Saves Allergan from Valeant Hostile Takeover with $66 Billion Deal, But Will Slash R&D

The seven-month battle over American Botox haven pharmaceutical company Allergan is over, after it accepted a friendly takeover bid from Irish integrated specialty pharmaceutical Actavis. The Actavis offer More...

Vered Weiss On Thursday, November 20th, 2014

Bill Ackman Finally Throws in the Towel with Allergan Shareholders’ Meeting

After an intense and acrimonious months long battle for a hostile takeover of Allergan, Bill Ackman, who owns a 9.7% stake in the company, finally gave up his battle to convene a special shareholders’ More...

Vered Weiss On Wednesday, November 19th, 2014

Jim Cramer: Is Zoetis Fending Off Ackman?

On CNBC’s Mad Dash segment, Jim Cramer discussed “one of my favorite stocks, ” Zoetis, an animal health drug company spun off by Pfizer. Cramer says he likes the stock, because animal More...

Reuters On Tuesday, November 18th, 2014

Ackman supports Allergan’s $66 billion sale to Actavis

– Activist investor William “Bill” Ackman said on Tuesday he supports the $66 billion deal in which Actavis PLC will buy Allergan Inc and will withdraw his request for an Allergan special shareholder More...

Wordpress site Developed by Fixing WordPress Problems